top of page


  • We have started our human trials with success and hold issued Canadian patents, have US patents pending, and are in the process of submitting EU and UK patent applications. 

  • We are looking to transform our prototype (MVP) into a  production model.

  • We have raised a quarter million dollars in a Family & Friends round

  • Currently in the process of closing a Seed Round which will allow us to engage an engineering firm, secure regulatory approvals, establish distribution partners and introduce our product to the market.


If you are interested in becoming an equity partner in GFR90 and participating in what looks to be a very promising future of of helping dialysis patients and an attractive payback for your investment, please click on the button below to hear an elevator pitch (52 s) and a pitch deck. Or connect with us directly - we would love to talk with you.

(C) GFR90 Inc. 2020.  This website is owned and operated by GFR90 Inc. These Terms set forth the terms and conditions under which you may use our website and services as offered by us. This website offers visitors a description of our products, our company and opportunities to invest or donate. By accessing or using the website of our service, you approve that you have read, understood, and agree to be bound by these Terms.

bottom of page